O-2372

O-2372

Identifiers
IUPAC name 6-((6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-3-yl)-6-methyl-1-morpholinoheptan-1-one
PubChem (CID)	24848987
ChemSpider	21259336
Chemical and physical data
Formula	C28H41NO4
Molar mass	455.629 g/mol
3D model (Jmol)	Interactive image
SMILES CC1(C)[C@H]2[C@@H](CC(C)=CC2)C3=C(C=C(C(C)(C)CCCCC(N4CCOCC4)=O)C=C3O)O1
InChI InChI=1S/C28H41NO4/c1-19-9-10-22-21(16-19)26-23(30)17-20(18-24(26)33-28(22,4)5)27(2,3)11-7-6-8-25(31)29-12-14-32-15-13-29/h9,17-18,21-22,30H,6-8,10-16H2,1-5H3/t21-,22-/m1/s1 Key:ASKNFEPPYVJXIA-FGZHOGPDSA-N
(what is this?)  (verify)

O-2372 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. It has high affinity for both CB₁ and CB₂ receptors, with K_i values of 1.3 nM at CB₁ and 0.57 nM at CB₂, but is only moderately soluble in water compared to other related compounds such as O-2694, which it is a metabolite of.^[1]

See also

• O-2113
• O-2545
• O-2694

References

1. Martin BR, et al. Pharmacological characterization of novel water-soluble cannabinoids. Journal of Pharmacology and Experimental Therapeutics. 2006 Sep;318(3):1230-9. PMID 16757541